Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

NCT00232115 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Perioral Dermatitis

Interventions

DRUG: Pimecrolimus
DRUG: Placebo

Sponsor

Novartis